Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pivotal, Prospective, Multi-center, Open-label Study Evaluating the Safety and Effectiveness of the CochlearTM Osia® 2 System in a Pediatric Population.

NCT05000931 is registered in ClinicalTrials.gov with Cochlear as lead sponsor.

NCT NCT05000931
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05000931 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pivotal, Prospective, Multi-center, Open-label Study Evaluating the Safety and Effectiveness of the CochlearTM Osia® 2 System in a Pediatric Population.
Lead sponsor
Cochlear
Phase
Not applicable
Overall status
Completed
Start date
January 26, 2022
Completion date
March 14, 2024
Enrollment
50 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

conductive hearing loss, mixed hearing loss, single-sided deafness